REFARMA
The computed 12-month bankruptcy probability of REFARMA is 0.6% (low). The company has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 36 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 28-08-2025 | 2025-00425504 |
| 31-12-2023 | micro | 30-08-2024 | 2024-00425126 |
| 31-12-2022 | micro | 31-08-2023 | 2023-00406506 |
| 31-12-2021 | micro | 14-06-2022 | 2022-20068055 |
| 31-12-2020 | micro | 27-08-2021 | 2021-56800121 |
| 31-12-2019 | micro | 05-10-2020 | 2020-59300500 |
| 31-12-2018 | verkort | 05-08-2019 | 2019-43900339 |
| 31-12-2017 | verkort | 27-08-2018 | 2018-51100483 |
| 31-12-2016 | verkort | 24-08-2017 | 2017-46900498 |
| 31-12-2015 | verkort | 31-08-2016 | 2016-53400418 |
| NACE primary | - |
| Legal form | Public limited company(014) |
| Incorporation | 20-12-1989 |
| Status | Active |
| Postal code | 3140 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24472F0370/00L000 | Flanders | 2,968 m² | 1 · 268 m² | 7.5 m · 2 fl. |
| 24094D0492/00S002 | Flanders | 650 m² | 1 · 127 m² | 7.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
13-09-2023 Transaction in capital or shares
Technical details
{
"events": [
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kristiaan Triau",
"firm_city": null,
"firm_name": null,
"office_city": "Rotselaar",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-09-13",
"filing_date": "2023-09-10",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-08-30",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0439.644.283",
"name_full": "REFARMA",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal der statutenwijziging",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 60,
"class_name": "Aandelen",
"capital_share_eur": 304909.0,
"voting_rights_per_share": 1.0
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | REFARMA |